Comparing two biologic drugs for ankylosing spondylitis
Part of Bones, joints & muscles clinical trials.
This study compares two types of biologic drugs (IL-17 inhibitors vs. anti-TNF drugs) in people with ankylosing spondylitis (a form of arthritis affecting the spine) who have already tried standard treatments. The goal is to see which drug works better for controlling symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with axial spondyloarthritis (a type of inflammatory arthritis in the spine) according to standard medical criteria.
- Your symptoms must have lasted more than 6 months.
- You have already tried standard treatments (like NSAIDs) and they didn't work, so you are now on a biologic drug (either an IL-17 inhibitor or an anti-TNF drug).
- You are between 16 and 60 years old.
- You are able to answer questions and give written permission to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at treatments for people with ankylosing spondylitis, a type of arthritis that affects the spine. It aims to find better ways to manage symptoms and improve quality of life.
This trial tests whether combining two biologic medications (adalimumab and secukinumab) can better relieve symptoms of ankylosing spondylitis, a type of arthritis that affects the spine. It may help if you have not responded well to standard nonsteroidal anti-inflammatory drugs (NSAIDs) and you have active disease.
This study is looking for people with ankylosing spondylitis, rheumatoid arthritis, or lupus to help find biomarkers that may make diagnosis easier. If you have one of these conditions and haven't tried biologic therapies, you may be able to join.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
This trial tests whether a single infusion of stem cells from a healthy donor's bone marrow can help reduce inflammation and pain in people with active ankylosing spondylitis. If you are young and have not been helped by standard treatments, this study might offer a new option.
This study tests a new treatment using umbilical cord stem cells given by injection to help reduce inflammation and improve symptoms of ankylosing spondylitis. It is for people who have not gotten enough relief from standard medications, including biologics.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.